NCT02688998View on ClinicalTrials.gov

REaCT-vascular Access Her2 Negative Vascular Access Strategies for (Neo) Adjuvant Breast Cancer Treatment Without Trastuzumab

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Breast CancerCancer
Interventions
DEVICE

venous access PORT or PICC

Participants will receive a venous access prior to starting chemotherapy

Trial Locations (1)

K1H 8L6

The Ottawa Hospital Cancer Centre, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER